The covid-19 pandemic has been accompanied by an explosion in scientific discourse across mainstream media, social media, preprint […]

No serious side effects were observed in the Phase I trial

Rate of rare blood clots with low platelets after the second dose is comparable to background rates observed […]

AC Immune is set to acquire Affiris’ entire portfolio of therapeutics targeting alpha-synuclein

Collaboration will focus on developing small molecule medicines targeting GPR75

To date, there are no effective antidotes against most virus infections. An interdisciplinary research team at the Technical […]

Bar-Ilan University researchers have developed nerve guidance conduits filled with smart gel that accelerate regeneration of torn nerve […]

Updated Date: Tue, 20 Jul 2021 00:00:00 EDT

‘I don’t like it:’ Biogen’s latest Alzheimer’s ad rouses fresh Aduhelm concerns—and some defense nhigginsdunn Tue, 07/27/2021 – […]

A model using simple changes in microbe growth curves could predict how drug resistance evolves in response to […]